BAZ1B

Across TCGA pan-cancer cohorts, BAZ1B mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated BAZ1B data layer compared with 28 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher BAZ1B mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated BAZ1B expression acts as an unfavorable survival marker, although some lineages such as LSCC and HNSC show a favorable association.

CCRCC, PDAC, and UCEC are the cancer types where BAZ1B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	All	0.857	0.974	.025	15	view →
PDAC	DFS	Quartile	II,III,IV	0.269	0.539	.003	12	view →
UCEC	DFS	Quartile	All	0.857	1.000	.012	6	view →
LSCC	DFS	Quartile	II,III,IV	0.763	0.463	.046	2	view →
HNSC	OS	Tertile	All	1.000	0.956	.042	2	view →
LUAD	DFS	Quartile	II,III,IV	0.985	0.732	.017	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

BAZ1B–CCRCC (OS)

Open the CCRCC breakdown →